nafenopin has been researched along with clofibrate in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (78.13) | 18.7374 |
| 1990's | 7 (21.88) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coloma, L; Koenig, C; Leighton, F | 1 |
| Salas, M; Tuchweber, B | 1 |
| Arias, IM; Fleischner, G; Gatmaitan, Z; Gluck, R; Levine, WG; Meijer, DK | 1 |
| Azarnoff, DL; Moody, DE; Rao, MS; Reddy, JK | 1 |
| Kumar, NS; Reddy, JK | 1 |
| Maier, R; Muller, K | 1 |
| Andreani, A; Andreani, F; Andrisano, R | 1 |
| Andersson, K; DePierre, JW; Eriksson, AM; Lundgren, B | 1 |
| Bursch, W; Gerbracht, U; Kraus, P; Putz, B; Reinacher, M; Schulte-Hermann, R; Timmermann-Trosiener, I | 1 |
| Beije, B; Erixon, K; Nilsson, R; Préat, V; Ramel, C | 1 |
| Bergstrand, A; DePierre, JW; Karlsson, K; Lundgren, B | 1 |
| Mostecká, H; Seifert, J | 1 |
| Fringes, B; Reith, A | 1 |
| Butler, EG; England, PJ; Williams, GM | 1 |
| Alvares, K; Lalwani, ND; Parikh, I; Reddy, JK; Reddy, MK; Reddy, MN | 1 |
| Amigo, L; Bronfman, M; Morales, MN | 1 |
| MacDonald, RS; Swan, PB | 1 |
| Dalton, C; Hope, HR; Hope, WC; Sheppard, H | 1 |
| Brecher, PI; Chobanian, AV | 1 |
| Moody, DE; Reddy, JK | 1 |
| Reddy, JK | 1 |
| Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
| Nikkila, EA | 1 |
| Cenedella, RJ | 1 |
| Azarnoff, D; Reddy, J; Svoboda, D | 1 |
| Furukawa, K; Furuya, K; Numoto, S; Williams, GM | 1 |
| Fahl, WE; Lalwani, ND; Reddy, JK | 1 |
| Reddy, JK; Simmon, VF; Warren, JR | 1 |
| Bieber, LL; Farrell, SO | 1 |
| Appelkvist, EL; Cai, Y; DePierre, JW | 1 |
| Gonzalez, FJ; McBride, OW; Sher, T; Yi, HF | 1 |
| Beaune, P; Foliot, A | 1 |
3 review(s) available for nafenopin and clofibrate
| Article | Year |
|---|---|
Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
Topics: Cholesterol; Clofibrate; Hydrogen Peroxide; Microbodies; Nafenopin; Organoids; Propionates; Steroids | 1973 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |
Effect of drugs on plasma triglyceride metabolism.
Topics: Adipose Tissue; Animals; Carbon Radioisotopes; Clofibrate; Contraceptives, Oral; Fatty Acids, Nonesterified; Female; Half-Life; Heparin; Humans; Isotope Labeling; Kinetics; Lipid Metabolism, Inborn Errors; Lipid Mobilization; Lipoprotein Lipase; Nafenopin; Nicotinic Acids; Palmitic Acids; Pharmacology; Steroids; Time Factors; Triglycerides; Tritium | 1972 |
29 other study(ies) available for nafenopin and clofibrate
| Article | Year |
|---|---|
Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
Topics: Acid Phosphatase; Animals; Antigens; Catalase; Cell Fractionation; Clofibrate; D-Amino-Acid Oxidase; Female; Histocytochemistry; Hydroxy Acids; Leucine; Liver; Male; Microbodies; Nafenopin; Organoids; Oxidoreductases; Propionates; Protein Biosynthesis; Rats; Urate Oxidase | 1975 |
Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.
Topics: Adenine; Animals; Cesium; Chemical and Drug Induced Liver Injury; Cholesterol; Clofibrate; Female; Hypolipidemic Agents; Liver; Nafenopin; Organ Size; Rats; Triglycerides | 1978 |
Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver.
Topics: Animals; Carrier Proteins; Clofibrate; Glutathione Transferase; Immunodiffusion; Immunoelectrophoresis; Liver; Male; Nafenopin; Organ Size; Propionates; Proteins; Rats | 1975 |
Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
Topics: Allylisopropylacetamide; Amitrole; Animals; Carnitine O-Acetyltransferase; Catalase; Clofenapate; Clofibrate; Lipids; Liver; Male; Microbodies; Microscopy, Electron; Nafenopin; Organ Size; Rats; Rats, Inbred F344 | 1977 |
The peroxisome proliferation-associated polypeptide in rat liver.
Topics: Acetates; Animals; Clofibrate; Liver; Male; Microbodies; Molecular Weight; Nafenopin; Organoids; Peptides; Propionates; Pyrimidines; Rats | 1977 |
Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
Topics: Animals; Cholesterol Esters; Clofibrate; Epididymis; Fatty Acids; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Male; Nafenopin; Nicotinic Acids; Oleic Acids; Palmitic Acids; Phospholipids; Rats; Thyroxine; Triglycerides | 1975 |
New alpha-substituted arylthioacetic derivatives forming analogues of clofibrate.
Topics: Animals; Butyrates; Clofibrate; Hyperlipidemias; Magnetic Resonance Spectroscopy; Male; Nafenopin; Rats; Sulfides | 1975 |
Is the cytosolic catalase induced by peroxisome proliferators in mouse liver on its way to the peroxisomes?
Topics: Animals; Catalase; Clofibrate; Cytosol; Enzyme Induction; Liver; Male; Mice; Mice, Inbred C57BL; Microbodies; Nafenopin; Pyrimidines | 1992 |
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Topics: Animals; Body Weight; Carcinogens; Cell Survival; Clofibrate; Cyproterone; Cyproterone Acetate; Female; Glutathione Transferase; Hexachlorocyclohexane; Liver; Liver Neoplasms, Experimental; Nafenopin; Nitrosamines; Organ Size; Phenobarbital; Phenotype; Precancerous Conditions; Propionates; Rats; Rats, Inbred Strains | 1990 |
On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.
Topics: Animals; Caprylates; Carcinogens; Clofibrate; Clofibric Acid; DNA; DNA Damage; DNA Repair; Fibric Acids; Fluorocarbons; Liver; Liver Neoplasms; Male; Microbodies; Micronucleus Tests; Mutagenicity Tests; Nafenopin; Radiation, Ionizing; Rats; Rats, Inbred Strains; S Phase | 1991 |
Effects of dietary treatment with clofibrate, nafenopin or WY-14.643 on mitochondria and DNA in mouse liver.
Topics: Animals; Anticholesteremic Agents; Cell Nucleus; Clofibrate; DNA; Enzymes; Liver; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Mitochondria, Liver; Nafenopin; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Reference Values | 1990 |
Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.
Topics: Animals; Clofibrate; DNA; Kidney; Liver; Male; Nafenopin; Orotic Acid; Propionates; Rats; Rats, Inbred Strains; RNA; Thymidine | 1988 |
Two hypolipidemic peroxisome proliferators increase the number of lamellar bodies in alveolar cells type II of the rat lung.
Topics: Animals; Clofibrate; Liver; Male; Microbodies; Nafenopin; Organ Size; Propionates; Pulmonary Alveoli; Pulmonary Surfactants; Rats; Rats, Inbred Lew | 1988 |
Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.
Topics: Animals; Carboxylic Ester Hydrolases; Cholinesterases; Clofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Microbodies; Nafenopin; Rats; Rats, Inbred F344; Rats, Inbred Strains; Species Specificity | 1988 |
Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver.
Topics: Animals; Carrier Proteins; Clofibrate; Clofibric Acid; Fibric Acids; Intracellular Signaling Peptides and Proteins; Liver; Male; Molecular Weight; Nafenopin; Propionates; Rats; Rats, Inbred F344 | 1987 |
Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters.
Topics: Acyl Coenzyme A; Animals; Chromatography, High Pressure Liquid; Clofibrate; Clofibric Acid; Coenzyme A Ligases; Fibric Acids; Hydrolysis; Male; Microsomes, Liver; Nafenopin; Propionates; Rats; Rats, Inbred Strains; Repressor Proteins; Saccharomyces cerevisiae Proteins; Spectrophotometry, Ultraviolet | 1986 |
The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle.
Topics: Animals; Body Weight; Catalase; Clofibrate; Clofibric Acid; Fibric Acids; Hypolipidemic Agents; Male; Microbodies; Mitochondria, Heart; Mitochondria, Muscle; Muscles; Myocardium; Nafenopin; Oxidation-Reduction; Palmitates; Palmitic Acids; Rats; Rats, Inbred Strains | 1986 |
Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
Topics: Animals; Cholesterol; Clofibrate; Dactinomycin; DNA; Dose-Response Relationship, Drug; Glycolates; Hepatomegaly; Hypolipidemic Agents; In Vitro Techniques; Liver; Male; Microsomes, Liver; Mitochondria, Liver; Nafenopin; Oxidoreductases, N-Demethylating; Phenobarbital; Phenyl Ethers; Phenytoin; Phospholipids; Piperazines; Piperidines; Propionates; Proteins; Rats; RNA; Spectrophotometry, Ultraviolet; Triglycerides | 1974 |
Cholesteryl ester synthesis in normal and atherosclerotic aortas of rabbits and rhesus monkeys.
Topics: Acyltransferases; Animals; Anticholesteremic Agents; Aorta; Arteries; Arteriosclerosis; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Clofibrate; Coenzyme A Ligases; Esters; Hydrogen-Ion Concentration; Macaca; Microsomes; Nafenopin; Oleic Acids; Rabbits | 1974 |
Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
Topics: Acetyltransferases; Animals; Biphenyl Compounds; Butyrates; Carnitine; Catalase; Clofibrate; Ethers; Female; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred Strains; Microbodies; Microscopy, Electron; Nafenopin; Organ Size; Organoids; Perfusion; Propionates; Rats; Sex Factors; Stimulation, Chemical | 1974 |
Clofibrate and nafenopin (SU-13437): effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog.
Topics: Adipose Tissue; Animals; Carbon Isotopes; Chylomicrons; Clofibrate; Dogs; Fasting; Hypolipidemic Agents; Lipoprotein Lipase; Liver; Male; Muscles; Nafenopin; Palmitic Acids; Propionates; Sodium Chloride; Triglycerides | 1972 |
Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
Topics: Animals; Catalase; Clofibrate; Hypolipidemic Agents; Levulinic Acids; Liver; Male; Microbodies; Microscopy, Electron; Nafenopin; Organ Size; Organoids; Precipitin Tests; Propionates; Rabbits; Rats; Rats, Inbred F344; Tritium | 1973 |
Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Alkaline Phosphatase; Animals; Body Weight; Cell Division; Cell Membrane; Clofibrate; gamma-Glutamyltransferase; Histocytochemistry; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Nafenopin; Organ Size; Propionates; Rats; Rats, Inbred F344 | 1984 |
Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds.
Topics: Animals; Carrier Proteins; Clofibrate; Clofibric Acid; Cytosol; Enzyme Induction; Fibric Acids; Kidney Cortex; Liver; Male; Microbodies; Nafenopin; Propionates; Rats; Rats, Inbred F344 | 1983 |
Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
Topics: Acetates; Animals; Clofibrate; Concanavalin A; DNA Replication; Glycolates; Hypolipidemic Agents; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred C57BL; Microbodies; Microsomes, Liver; Mutagens; Nafenopin; Organoids; Piperidines; Pyrimidines; Rats; Salmonella typhimurium; Thioacetamide; Thymidine | 1980 |
Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs.
Topics: Acyltransferases; Animals; Carnitine Acyltransferases; Clofibrate; Enzyme Activation; Hypolipidemic Agents; Kinetics; Liver; Male; Mice; Microbodies; Nafenopin; Organoids; Subcellular Fractions | 1983 |
Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
Topics: Acyl Coenzyme A; Amitrole; Animals; Aspirin; Caprylates; Catalase; Clofibrate; Decanoic Acids; Diet; Fluorocarbons; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Lipid Peroxidation; Liver; Mice; Mice, Inbred C57BL; Microbodies; Microsomes, Liver; Mitochondria, Liver; NAD(P)H Dehydrogenase (Quinone); Nafenopin; Oxidation-Reduction; Oxidative Stress; Palmitoyl Coenzyme A; Superoxide Dismutase; Ubiquinone; Vitamin E | 1995 |
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.
Topics: Acyl-CoA Oxidase; Amino Acid Sequence; Animals; Base Sequence; Chloramphenicol O-Acetyltransferase; Chromosome Mapping; Chromosomes, Human, Pair 22; Clofibrate; Cloning, Molecular; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; DNA; Gene Library; Genetic Linkage; Humans; Lod Score; Mice; Microbodies; Mixed Function Oxygenases; Molecular Sequence Data; Nafenopin; Oligodeoxyribonucleotides; Oxidoreductases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Promoter Regions, Genetic; Pyrimidines; Rabbits; Rats; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Thymidine Kinase; Transcription Factors | 1993 |
Effects of microsomal enzyme inducers on glutathione S-transferase isoenzymes in livers of rats and hamsters.
Topics: Animals; Clofibrate; Cricetinae; Cytochrome P-450 Enzyme System; Cytosol; Enzyme Induction; Fenofibrate; Glutathione Transferase; Isoenzymes; Male; Microsomes, Liver; Nafenopin; Organ Size; Rats; Rats, Sprague-Dawley; Substrate Specificity | 1994 |